Application Progress of P2Y12 Receptor Inhibitors in Dual Antiplatelet Therapy After PCI in Patients with Acute Myocardial Infarction
Abstract：Acute myocardial infarction (acute myocardial infarction, AMI) is a severe type of coronary atherosclerotic heart disease (coronary heart disease), which has a high incidence and mortality [1]. Among patients with AMI in China, a large proportion are elderly [2]; the main pathogenesis of this disease is due to hemorrhage within or under the intima of atherosclerotic plaques in the coronary arteries, leading to thrombosis or prolonged arterial spasm, complete occlusion of the lumen, causing myocardial ischemia, hypoxia, or even necrosis.
Machine-generated Keywords：
Publication Date：2025-02-20
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 254-256 )